Platelets as pivot in the antiphospholipid syndrome

Por de Groot, Philip G.
Publicado em 2014

Pathogenic Role of Antiphospholipid Antibodies

Por Salmon, Jane E., de Groot, Philip G.
Publicado em 2008

Autoantibodies Directed Against Domain I of Beta2-Glycoprotein I

Por de Laat, Bas, de Groot, Philip G.
Publicado em 2010

Up-regulation of platelet activation in hemophilia A

Por van Bladel, Esther R., Roest, Mark, de Groot, Philip G., Schutgens, Roger E.G.
Publicado em 2011

Chlamydia trachomatis Infection of Human Mesothelial Cells Alters Proinflammatory, Procoagulant, and Fibrinolytic Responses

Por van Westreenen, Mireille, Pronk, Apollo, Diepersloot, Rob J. A., de Groot, Philip G., Leguit, Piet
Publicado em 1998

Synergistic Effects of Hypofibrinolysis and Genetic and Acquired Risk Factors on the Risk of a First Venous Thrombosis

Por Meltzer, Mirjam E, Lisman, Ton, Doggen, Carine J. M, de Groot, Philip G, Rosendaal, Frits R
Publicado em 2008

The rate of hemolysis in sickle cell disease correlates with the quantity of active von Willebrand factor in the plasma

Por Chen, Junmei, Hobbs, William E., Le, Jennie, Lenting, Peter J., de Groot, Philip G., López, José A.
Publicado em 2011

Synergism between platelet collagen receptors defined using receptor-specific collagen-mimetic peptide substrata in flowing blood

Por Pugh, Nicholas, Simpson, Anna M. C., Smethurst, Peter A., de Groot, Philip G., Raynal, Nicolas, Farndale, Richard W.
Publicado em 2010

Endocannabinoids Control Platelet Activation and Limit Aggregate Formation under Flow

Por De Angelis, Valentina, Koekman, Arnold C., Weeterings, Cees, Roest, Mark, de Groot, Philip G., Herczenik, Eszter, Maas, Coen
Publicado em 2014

Activated factor V is a cofactor for the activation of factor XI by thrombin in plasma

Por Maas, Coen, Meijers, Joost C. M., Marquart, J. Arnoud, Bakhtiari, Kamran, Weeterings, Cees, de Groot, Philip G., Urbanus, Rolf T.
Publicado em 2010

Variability in Exposure of Epitope G40-R43 of Domain I in Commercial Anti-Beta2-Glycoprotein I IgG ELISAs

Por Pelkmans, Leonie, Kelchtermans, Hilde, de Groot, Philip G., Zuily, Stephane, Regnault, Veronique, Wahl, Denis, Pengo, Vittorio, de Laat, Bas
Publicado em 2013

Low thrombin activatable fibrinolysis inhibitor activity levels are associated with an increased risk of a first myocardial infarction in men

Por Meltzer, Mirjam E., Doggen, Carine J.M., de Groot, Philip G., Meijers, Joost C.M., Rosendaal, Frits R., Lisman, Ton
Publicado em 2009

Cleavage of von Willebrand Factor by Granzyme M Destroys Its Factor VIII Binding Capacity

Por Hollestelle, Martine J., Lai, Ka Wai, van Deuren, Marcel, Lenting, Peter J., de Groot, Philip G., Sprong, Tom, Bovenschen, Niels
Publicado em 2011

Interference with the Host Haemostatic System by Schistosomes

Por Mebius, Mirjam M., van Genderen, Perry J. J., Urbanus, Rolf T., Tielens, Aloysius G. M., de Groot, Philip G., van Hellemond, Jaap J.
Publicado em 2013

Pre-existing endothelial cell activation predicts vasoplegia after mitral valve surgery(†)

Por Kortekaas, Kirsten A., Lindeman, Jan H.N., Reinders, Marlies E.J., Palmen, Meindert, Klautz, Robert J.M., de Groot, Philip G., Roest, Mark
Publicado em 2013

Circulating Biomarkers for Predicting Cardiovascular Disease Risk; a Systematic Review and Comprehensive Overview of Meta-Analyses

Por van Holten, Thijs C., Waanders, Leonie F., de Groot, Philip G., Vissers, Joost, Hoefer, Imo E., Pasterkamp, Gerard, Prins, Menno W. J., Roest, Mark
Publicado em 2013

Thrombin-dependent Incorporation of von Willebrand Factor into a Fibrin Network

Por Miszta, Adam, Pelkmans, Leonie, Lindhout, Theo, Krishnamoorthy, Ganeshram, de Groot, Philip G., Hemker, Coenraad H., Heemskerk, Johan W. M., Kelchtermans, Hilde, de Laat, Bas
Publicado no J Biol Chem (2014)

The Functions of the A1A2A3 Domains in Von Willebrand Factor Include Multimerin 1 Binding

Por Parker, D’Andra N., Tasneem, Subia, Farndale, Richard W., Bihan, Dominique, Sadler, J. Evan, Sebastian, Silvie, De Groot, Philip G., Hayward, Catherine P. M.
Publicado no Thromb Haemost (2016)

Platelet Activation Determines Angiopoietin-1 and VEGF Levels in Malaria: Implications for Their Use as Biomarkers

Por Brouwers, Judith, Noviyanti, Rintis, Fijnheer, Rob, de Groot, Philip G., Trianty, Leily, Mudaliana, Siti, Roest, Mark, Syafruddin, Din, van der Ven, Andre, de Mast, Quirijn
Publicado em 2013

Identification of coagulation factor XI as a ligand for platelet apolipoprotein E receptor 2 (ApoER2)

Por White-Adams, Tara C., Berny, Michelle A., Tucker, Erik I., Gertz, Jacqueline M., Gailani, David, Urbanus, Rolf T., de Groot, Philip G., Gruber, András, McCarty, Owen J. T.
Publicado em 2009